Bing

SEARCH HISTORY

But Tuesday's selloff had the whiff of liquidation. The selling in biotech generals like Celgene (CELG) and Amgen (AMGN), which had recently set new highs, leaves a sour taste on the tape. Who needs to get glamours like this off their books at the end of ...
Minyanville · ByJeffrey Cooper · 4/1/2015
A U.S. appeals court has blocked the sale of Novartis AG's recently approved "biosimilar" form of Neupogen, Amgen Inc's AMGN.O blockbuster drug used to prevent infections in cancer patients. The Swiss drugmaker said European health regulators have …
Reuters · 5/8/2015
Amgen (NASDAQ:AMGN) was up 0.4 percent after posting profit that topped projections and raising its forecast. Chipotle Mexican Grill (NYSE:CMG) fell 7.6 percent to 639.66 after the burrito chain posted the slowest same-restaurant sales growth in five …
Proactive Investors Australia · 4/22/2015
More from Bing News
Third Point LLC hedge fund manager Daniel Loeb, a major shareholder in Amgen Inc. (AMGN), is telling the big biotech it should break into two separate companies to "unlock hidden value." The idea would be to split Amgen into a one company that would …
The Deal Pipeline · 10/22/2014
But hedge fund manager and Apple shareholder David Einhorn, who is pushing the maker of iEverything to reward investors with a new class of high-yielding stock, has a point ... Cook noted how much the company was spending on capital expenditures …
CNN Money · ByPaul R. La · 2/12/2013
U.S. News evaluated 32 Health/Biotechnology Funds ETFs and 17 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
USNews · 2/24/2015